Search

everythinglearnresearchcommunity

for

Search:↓

Topical drugs and near-infrared light therapy show potential for treating alopecia.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Platelet-rich plasma (PRP) treatment has been found effective in promoting hair growth for alopecia patients, with minimal side effects like temporary pain and redness.

Most hair loss disorders can be accurately diagnosed and treated in an outpatient setting.

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

White hair regrowth in alopecia areata may be more common than thought.

COVID-19 infection and vaccination may trigger hair loss and rapid hair whitening.

Alopecia areata can be an early sign of Hodgkin’s lymphoma and may improve with lymphoma treatment.

Systemic steroids effectively treated severe nail issues in a card illusionist with alopecia areata.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.

88% phenol is effective for treating alopecia areata.

Hepatitis C treatment may trigger complete hair loss, especially in those with a history of patchy hair loss, but hair usually grows back within a year.

Alopecia areata patients have higher levels of IL-6 and TNF-α.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Permanent hair dye may cause total hair loss.

Oral mini-pulse methylprednisolone is an effective and safe treatment for alopecia areata.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Hamilton scale imprecise, hair shaft diameter decreases, stem cell transplant regrows hair, ECP ineffective for alopecia areata universalis.

Alopecia areata in Romania has a high economic burden, with significant costs and unequal healthcare access.